Epidemiological profile of patients with multiple myeloma who developed pulmonary complications after hematopoietic stem cell transplantation

Jaime Leonardo Chacón Manosalva, Luis Antonio Salazar Montaña, Angela María Peña Castellanos, Manuel Leonidas Rosales Acevedo (Co-author), Jonathan Javier Díaz Jurado, Ana Maria Prada Sepulveda, Miguel Enrique Ochoa Vera, Gabriela Vesga Jerez, Maria Angelica Chacon Manosalva, Claudia Lucia Sossa Melo

Research output: Articles / NotesScientific Articlepeer-review


Multiple myeloma (MM) is a neoplastic entity for which Hematopoietic Stem Cell Transplantation (HSCT) is a therapeutic option. Between 30–60% of patients managed with HSCT have pulmonary complications (PC). The aim of this study was to identify the clinical and sociodemographic characteristics associated with the incidence of PC in patients with MM after HSCT (post-HSCT) at Clinica FOSCAL.
Original languageUndefined/Unknown
Article numberP412
Pages (from-to)324-325
Number of pages1
JournalBone Marrow Transplantation
Issue numberpag. 326
StatePublished - 1 Nov 2022

Research Areas UNAB

  • Medicina Interna

Cite this